Clinical Trial Update: Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial of Avastin (bevacizumab) with fluorouracil, doxorubicin, and streptozocin in locally advanced and metastatic pancreatic neuroendocrine tumors; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• 5-FU (5-fluorouracil) (5-fluorouracil)
• Avastin (bevacizumab)
• Doxorubicin (Adriamycin) (doxorubicin)
• Streptozocin (streptozocin)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2011-03-22